Algernon Pharmaceuticals Inc (AGNPF)
0.082
0.00 (0.00%)
USD |
OTCM |
Jun 25, 16:00
Algernon Pharmaceuticals 1 Year Total Returns (Daily): -51.76% for June 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 25, 2024 | -51.76% |
| June 24, 2024 | -51.76% |
| June 21, 2024 | -58.03% |
| June 20, 2024 | -50.59% |
| June 18, 2024 | -47.06% |
| June 17, 2024 | -47.06% |
| June 14, 2024 | -41.68% |
| June 13, 2024 | -42.18% |
| June 12, 2024 | -39.37% |
| June 11, 2024 | -33.92% |
| June 10, 2024 | -31.30% |
| June 07, 2024 | -44.66% |
| June 06, 2024 | -45.14% |
| June 05, 2024 | -33.73% |
| June 04, 2024 | -40.54% |
| June 03, 2024 | -37.82% |
| May 31, 2024 | -24.13% |
| May 30, 2024 | -30.87% |
| May 29, 2024 | -33.19% |
| May 28, 2024 | -28.66% |
| May 24, 2024 | -31.60% |
| May 23, 2024 | -33.32% |
| May 22, 2024 | -31.93% |
| May 21, 2024 | -47.95% |
| May 20, 2024 | -47.95% |
| Date | Value |
|---|---|
| May 17, 2024 | -46.52% |
| May 16, 2024 | -50.79% |
| May 15, 2024 | -48.14% |
| May 14, 2024 | -46.62% |
| May 13, 2024 | -53.74% |
| May 10, 2024 | -54.02% |
| May 09, 2024 | -60.22% |
| May 08, 2024 | -54.65% |
| May 07, 2024 | -56.29% |
| May 06, 2024 | -61.67% |
| May 03, 2024 | -60.74% |
| May 02, 2024 | -58.45% |
| May 01, 2024 | -58.73% |
| April 30, 2024 | -56.66% |
| April 29, 2024 | -56.66% |
| April 26, 2024 | -59.36% |
| April 25, 2024 | -61.12% |
| April 24, 2024 | -57.62% |
| April 23, 2024 | -52.44% |
| April 22, 2024 | -61.74% |
| April 19, 2024 | -57.62% |
| April 18, 2024 | -63.68% |
| April 17, 2024 | -65.00% |
| April 16, 2024 | -63.74% |
| April 15, 2024 | -63.17% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.55%
Minimum
Nov 16 2023
879.5%
Maximum
Dec 14 2020
-15.23%
Average
-63.58%
Median
Mar 20 2023
1 Year Total Returns (Daily) Benchmarks
| Acasti Pharma Inc | -7.69% |
| Aurinia Pharmaceuticals Inc | -39.65% |
| Edesa Biotech Inc | -31.04% |
| Lexaria Bioscience Corp | 227.7% |
| Xenon Pharmaceuticals Inc | -7.52% |